KK
SNDX icon

KLP Kapitalforvaltning’s Syndax Pharmaceuticals SNDX Stock Holding History

KLP Kapitalforvaltning’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Hold
17,600
– – ﹤0.01% 1626
2026
Q1 		$411K Hold
17,600
– – ﹤0.01% 1509
2025
Q4 		$370K Buy
17,600
+1,000
+6% +$17.4K ﹤0.01% 1559
2025
Q3 		$255K Hold
16,600
– – ﹤0.01% 1718
2025
Q2 		$155K Hold
16,600
– – ﹤0.01% 1874
2025
Q1 		$204K Hold
16,600
– – ﹤0.01% 1736
2024
Q4 		$219K Buy
+16,600
New +$284K ﹤0.01% 1779

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

KLP Kapitalforvaltning's SNDX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 17,600 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

KLP Kapitalforvaltning first reported a position in SNDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $411K in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • KLP Kapitalforvaltning held 17,600 shares of Syndax Pharmaceuticals worth $385K as of Q2 2026.
  • KLP Kapitalforvaltning left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1626 holding.
  • KLP Kapitalforvaltning first reported a position in Syndax Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Syndax Pharmaceuticals position peaked at $411K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.